Page 4 - Director Laurence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director laurence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Laurence Today - Breaking & Trending Today

TG Therapeutics (NASDAQ:TGTX) Issues Earnings Results

TG Therapeutics (NASDAQ:TGTX – Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.03, Briefing.com reports. The company had revenue of $43.97 million during the quarter, compared to the consensus estimate of $40.06 million. TG Therapeutics had […] ....

Laurencen Charney , Jefferies Financial Group , Pricet Rowe Associates Inc , Securities Exchange Commission , Exome Asset Management , Group Plc , Goldman Sachs Group , Tg Therapeutics Inc , Tg Therapeutics Company Profile , Jpmorgan Chase Co , Get Free Report , Trading Down , Financial Group , Director Laurence , Exchange Commission , Asset Management , General Group Plc ,

TG Therapeutics (NASDAQ:TGTX) Issues Earnings Results

TG Therapeutics (NASDAQ:TGTX) Issues Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Laurencen Charney , Group Plc , Goldman Sachs Group , Jpmorgan Chase Co , Tg Therapeutics Company Profile , Tg Therapeutics Inc , Jefferies Financial Group , Securities Exchange Commission , Pricet Rowe Associates Inc , Exome Asset Management , Get Free Report , Trading Down , Financial Group , Director Laurence , Exchange Commission , Asset Management , General Group Plc ,

Recent Investment Analysts' Ratings Changes for TG Therapeutics (TGTX)

TG Therapeutics (NASDAQ: TGTX) has recently received a number of price target changes and ratings updates: 2/29/2024 – TG Therapeutics had its price target raised by analysts at The Goldman Sachs Group, Inc. from $12.00 to $13.00. They now have a “neutral” rating on the stock. 2/28/2024 – TG Therapeutics had its “buy” rating reaffirmed […] ....

Laurencen Charney , Macquarie Group Ltd , Goldman Sachs Group Inc , Tg Therapeutics Inc , Coppell Advisory Solutions , Financial Services Group Inc , Securities Exchange Commission , Tg Therapeutics Inc Daily , Pingora Partners , Goldman Sachs Group , Trading Down , Get Free Report , Exchange Commission , Director Laurence , Services Group , Advisory Solutions , Inc Daily , Nasdaq Tgtx ,

TG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX)

TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders acquired 18,866 call options on the company. This is an increase of 122% compared to the typical daily volume of 8,484 call options. Analyst Upgrades and Downgrades Several brokerages have recently issued reports on TGTX. Jefferies […] ....

United States , New York , Laurencen Charney , Valeo Financial Advisors , Jefferies Financial Group , Securities Exchange Commission , York State Common Retirement Fund , Tg Therapeutics Inc , Cim Investment Management Inc , Kestra Advisory Services , Jpmorgan Chase Co , Get Free Report , Financial Group , Director Laurence , Exchange Commission , Investment Management , Advisory Services , State Retirement System , Financial Advisors ,

Stock Traders Buy High Volume of Call Options on TG Therapeutics (NASDAQ:TGTX)

TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) saw some unusual options trading on Wednesday. Investors bought 18,866 call options on the company. This represents an increase of approximately 122% compared to the typical volume of 8,484 call options. Wall Street Analysts Forecast Growth Several equities research analysts recently issued reports on TGTX shares. JPMorgan […] ....

Laurencen Charney , Securities Exchange Commission , Coppell Advisory Solutions , Financial Services Group Inc , Tg Therapeutics Inc , Jpmorgan Chase Co , Jefferies Financial Group , Pingora Partners , Providence Capital Advisors , Get Free Report , Director Laurence , Exchange Commission , Advisory Solutions , Capital Advisors , Services Group ,